Cantor Fitzgerald Initiates Coverage On Odyssey Therapeutics with Overweight Rating
TD Cowen Initiates Coverage On Odyssey Therapeutics with Buy Rating
Wedbush Initiates Coverage On Odyssey Therapeutics with Outperform Rating, Announces Price Target of $30
JP Morgan Initiates Coverage On Odyssey Therapeutics with Overweight Rating, Announces Price Target of $26
Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.
